DART
Overview

Bridge has performed Developmental and Reproductive Toxicology (DART) studies at its US facility for more than a decade. DART is an important specialization within the comprehensive Bridge preclinical toxicology offering, which is why we maintain a dedicated DART facility in the US to support ongoing client research. Our technical staff has the deep DART experience and expertise required to carry out the full range of GLP-compliant DART studies — studies that meet the highest scientific and regulatory standards (ICH, FDA, EPA, OECD, EU and MOHW).
Wide Range of DART Services
Our DART expertise and capabilities can be utilized by clients across a broad array of study types, including:
-
Fertility (male and/or female) - Segment I
-
Embryo-fetal development - Segment II
-
Prenatal and postnatal development, including maternal function - Segment III
-
Multigenerational
-
Neurotoxicity
-
Neonatal dosing
At Bridge, we are experienced and skilled in undertaking DART studies that utilize both routine and specialized routes of administration:
Services to Meet Specialized Requirements
|
Bridge’s specialized DART services include:
|
